Medpace Holdings (MEDP) Interest Expenses (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Interest Expenses data on file, last reported at $189.5 million in Q2 2026.

• Quarterly Interest Expenses fell 4.24% year-over-year to $189.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $189.5 million (down 4.24% YoY) and the FY2025 annual result came in at $180.9 million, up 707.08% from the prior year.
• Interest Expenses slipped to $189.5 million in Q2 2026, from $193.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $223.4 million in Q1 2022 to a low of -$7.5 million in Q4 2023.
• A 5-year average of $161.8 million and a median of $201.9 million in 2024 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses plunged 250.96% — and 2025, when it jumped 197.53%.
• Tracing MEDP's Interest Expenses over 5 years: stood at $5.0 million in 2022, then sank by 250.96% to -$7.5 million in 2023, then gained by 2.02% to -$7.3 million in 2024, then jumped by 197.53% to $7.2 million in 2025, then jumped by 2550.15% to $189.5 million in 2026.
• The last three Interest Expenses figures came in at $189.5 million (Q2 2026), $193.1 million (Q1 2026), and $7.2 million (Q4 2025), per Business Quant data.